Why the study?
Do AGT and AT1 receptor gene polymorphisms contribute to the development of arterial hypertension in patients with NIDDM?
Population
French Caucasian families including 179 hypertensive sibpairs from 69 non-insulin-dependent diabetes…
Comparison
Assessment of M235T and T174M polymorphisms of… vs Control subjects with NIDDM alone, hypertension…
Design
Case-control
Authors
Loading...
No association seen in this case-control study; leaves open whether AGT/AT1 loci contribute to hypertension in NIDDM and warrants larger replication.
Do AGT and AT1 receptor gene polymorphisms contribute to the development of arterial hypertension in patients with NIDDM?
Polymorphisms in the AGT and AT1 receptor genes do not appear to be major genetic determinants of hypertension in French Caucasian patients with NIDDM.
Lesage et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: